ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,870.62
      -1.32%
      US Tech 100
      19,880.00
      -2.30%
      Dow Jones
      43,444.99
      -0.70%
      Brent Oil
      70.895
      0.00%
      Bitcoin
      91,366.60
      0.34%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Terns Pharmaceuticals Inc (TERN)

      7. Terns Pharmaceuticals Inc (TERN) Financials

      Terns Pharmaceuticals Inc

      Terns Pharmaceuticals Inc (TERN)

      Tern Plc
      6.17
      -0.38
      (-5.80%)
      Closed November 16 4:00PM
      Delayed by 15 minutes
      6.4643
      0.2943
      (4.77%)
      After Hours: 7:02PM
      Delayed by 15 minutes

      Terns Pharmaceuticals Inc Financial Summary

      The current TERN market cap is 454.91M. The company's latest EPS is USD -1.2819 and P/E is -4.81.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -21.16M-33.18M-24.06M-25.45M-25.54M
      Net Income -17.9M-29.77M-21.02M-22.37M-22.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 001M00
      Operating Income -70.2M-37.03M-49.86M-62.03M-102.56M
      Net Income -68.61M-29.35M-50.16M-60.35M-90.21M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 289.7M271.69M268.52M246.77M230.88M
      Total Liabilities 15.55M13.26M13.15M10.05M12.2M
      Total Equity 274.15M258.43M255.37M236.72M218.68M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 23.9M92.29M168.07M287.03M268.52M
      Total Liabilities 19.7M23.7M7.77M10.08M13.15M
      Total Equity -90.76M-117.44M160.3M276.94M255.37M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -27.38M-48.07M-67.39M-22.8M-38.98M
      Investing -62.91M-85.22M-37.99M8M50.19M
      Financing 28.07M28.09M41.95M N/A 399k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -66.22M-29.81M-41.83M-49.11M-67.39M
      Investing -3.86M6.69M-119.7M-22.27M-37.99M
      Financing 62k85.52M134.39M167.1M41.95M

      Stats and Ratios

      Market Cap 454.91M
      Price to Earnings Ratio -4.81
      Price to Sales Ratio 0
      Price to Cash Ratio 5.42
      Price to Book Ratio 1.7
      Dividend Yield -

      Share Statistics

      Shares Outstanding 70.37M
      Average Volume (1 week) 1.36M
      Average Volume (1 Month) 1.29M
      52 Week Change 84.17%
      52 Week High 11.40
      52 Week Low 3.51
      Spread (Intraday) 4.38 (42.9%)

      Company Info

      Company Name Terns Pharmaceuticals Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.ternspharma.com
      Industry pharmaceutical preparations (2834)